Episode 36: Sofinnova Invetments' Jim Healy
BioVenture VoiCes with Chris Garabedian
00:00
Regulatory clarity as a diligence pillar
Jim emphasizes assessing FDA division guidance, meeting minutes, and SPA use to gauge approval likelihood.
Play episode from 43:03
Transcript
